
A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer
Keywords: CRPC; castration-resistant prostate cancer; PI3K; Phosphatidylinositol-4,5-bisphosphate 3 kinase; PTEN; Phosphatase and tensin homolog; mTOR; mammalian target of rapamycin; BrdU; bromodeoxy-uridine; FITC; Fluorescein isothiocyanate; Skp2; S phase kinase-a